“Mathemalchemy” has been described as “a mathematics fever dream turned artistic playground for all math lovers (and haters, too).” ...

Irit Dinur's journey through mathematics and computer science led her to become the first woman professor at the Institute for Advanced Study.

Please view our affiliate disclosure. The way we approach education, particularly in mathematics, has changed a lot over the past few years. As students face increasingly complex math problems, ...

The four-year Mathematics MSci offers an additional year on top of the Mathematics BSc, allowing students to specialise further by taking more advanced modules, and undertaking a major final-year ...

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has recently achieved a significant milestone with the FDA's approval of JOURNAVX(suzetrigine), a novel non-opioid pain medication. This approval marks ...

Is this program for me? The Master’s program in Curriculum and Instruction - Mathematics Education produces educators in mathematics who are well versed in current research and theories about ...

Vertex Machineries Limited (VML) was incorporated as a Private Limited Company on 12th September 1994 under the companies Act, 1956 and converted into a public Limited Company by passing a special ...

At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown its team year-over-year. At a time when many life sciences companies are ...

AlgoTx’s mid-stage stumble on Tuesday comes after Vertex earlier this month won the FDA’s approval for Journavx, an inhibitor of the NaV1.8 voltage-gated sodium channel that marks the first new ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business.

Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...